IS6110 (n = 22; b12,004) AUC = 0.99
|
Sensitivity
|
0.79 (0.77–0.81)
|
470.30
|
95.50%
|
< 0.001
|
Specificity
|
0.98 (0.98–0.98)
|
150.16
|
86.00%
|
< 0.001
|
Positive likelihood ratio (PLR)
|
31.76 (20.12–50.13)
|
134.64
|
84.40%
|
< 0.001
|
Negative likelihood ratio (NLR)
|
0.17 (0.12–0.24)
|
356.22
|
94.10%
|
< 0.001
|
Diagnostic odds ratio (DOR)
|
243.69 (127.07–437.37)
|
141.04
|
85.10%
|
< 0.001
|
16S rRNA (n = 7; b12,074) AUC = 0.97
|
Sensitivity
|
0.69 (0.66–0.72)
|
45.85
|
86.90%
|
< 0.001
|
Specificity
|
0.99 (0.99–0.99)
|
32.10
|
81.30%
|
< 0.001
|
Positive likelihood ratio (PLR)
|
67.64 (36.40–125.70)
|
34.60
|
82.50%
|
< 0.001
|
Negative likelihood ratio (NLR)
|
0.29 (0.24–0.36)
|
19.87
|
69.8%
|
0.003
|
Diagnostic odds ratio (DOR)
|
287.19 (193.85–425.46)
|
9.12
|
34.20%
|
0.167
|
Other genes (n = 17; b11,870) AUC = 0.98
|
Sensitivity
|
0.82 (0.80–0.84)
|
413.02
|
96.10%
|
< 0.001
|
Specificity
|
0.99 (0.99–0.99)
|
173.35
|
90.80%
|
< 0.001
|
Positive likelihood ratio (PLR)
|
42.48 (20.66–87.36)
|
123.92
|
87.10%
|
< 0.001
|
Negative likelihood ratio (NLR)
|
0.22 (0.13–0.37)
|
498.03
|
96.80%
|
< 0.001
|
Diagnostic odds ratio (DOR)
|
234.56 (86.01–639.63)
|
125.08
|
87.20%
|
< 0.001
|